OSCR OSCAR HEALTH INC revenue, earnings and financials
For the quarter ended June 30, 2026, OSCAR HEALTH INC reported revenue of $4.88B (up 70.4% from a year earlier), net income of $362M and diluted EPS of $1.10; over the last four quarters revenue was $15.3B and net income $551M; for the fiscal year ended December 2025 revenue was $11.7B, up 27.5% on the year before.
OSCR annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $11.7B, gross profit n/a, operating income −$396M, net income −$443M (margin -3.8%), EPS −$1.69
- Fiscal year ended Dec 2024: revenue $9.18B, gross profit n/a, operating income $57.3M, net income $25.4M (margin 0.3%), EPS $0.10
- Fiscal year ended Dec 2023: revenue $5.86B, gross profit n/a, operating income −$236M, net income −$271M (margin -4.6%), EPS −$1.22
- Fiscal year ended Dec 2022: revenue $3.96B, gross profit n/a, operating income −$590M, net income −$606M (margin -15.3%), EPS −$2.85
- Fiscal year ended Dec 2021: revenue $1.84B, gross profit n/a, operating income −$544M, net income −$573M (margin -31.1%), EPS −$3.20
OSCR quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $4.88B (up 70.4% year over year), net income $362M, EPS $1.10
- Quarter ended Mar 31, 2026: revenue $4.65B (up 52.6% year over year), net income $679M, EPS $2.07
- Quarter ended Dec 31, 2025 (from the annual report): revenue $2.81B (up 17.3% year over year), net income −$353M, EPS −$1.19
- Quarter ended Sep 30, 2025: revenue $2.99B (up 23.2% year over year), net income −$137M, EPS −$0.53
- Quarter ended Jun 30, 2025: revenue $2.86B (up 29.0% year over year), net income −$228M, EPS −$0.89
- Quarter ended Mar 31, 2025: revenue $3.05B (up 42.2% year over year), net income $275M, EPS $0.92
- Quarter ended Dec 31, 2024 (from the annual report): revenue $2.39B (up 67.1% year over year), net income −$154M, EPS −$0.50
- Quarter ended Sep 30, 2024: revenue $2.42B (up 68.3% year over year), net income −$54.6M, EPS −$0.22
- Quarter ended Jun 30, 2024: revenue $2.22B (up 45.9% year over year), net income $56.2M, EPS $0.20
- Quarter ended Mar 31, 2024: revenue $2.14B (up 45.8% year over year), net income $177M, EPS $0.62
- Quarter ended Dec 31, 2023 (from the annual report): revenue $1.43B (up 43.9% year over year), net income −$150M, EPS −$0.68
- Quarter ended Sep 30, 2023: revenue $1.44B (up 47.2% year over year), net income −$65.4M, EPS −$0.29
- Quarter ended Jun 30, 2023: revenue $1.52B (up 49.6% year over year), net income −$15.5M, EPS −$0.07
- Quarter ended Mar 31, 2023: revenue $1.47B (up 51.1% year over year), net income −$39.8M, EPS −$0.18
- Quarter ended Dec 31, 2022 (from the annual report): revenue $995M (up 100.6% year over year), net income −$226M, EPS −$1.05
- Quarter ended Sep 30, 2022: revenue $978M (up 120.4% year over year), net income −$193M, EPS −$0.91
- Quarter ended Jun 30, 2022: revenue $1.02B (up 92.2% year over year), net income −$112M, EPS −$0.53
- Quarter ended Mar 31, 2022: revenue $973M (up 163.3% year over year), net income −$75.2M, EPS −$0.36
- Quarter ended Dec 31, 2021 (from the annual report): revenue $496M, net income −$199M, EPS −$0.83
- Quarter ended Sep 30, 2021: revenue $444M, net income −$211M, EPS −$1.02
OSCR cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $1.09B, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow $978M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$272M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow $380M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$182M, share buybacks $0
OSCR balance sheet
- Jun 30, 2026: cash $4.08B, total assets $11.2B, total liabilities $9.17B, shareholders' equity $2.05B, long-term debt $432M
- Mar 31, 2026: cash $4.81B, total assets $9.29B, total liabilities $7.62B, shareholders' equity $1.66B, long-term debt $431M
- Dec 31, 2025: cash $2.77B, total assets $6.33B, total liabilities $5.34B, shareholders' equity $978M, long-term debt $430M
- Sep 30, 2025: cash $2.15B, total assets $5.75B, total liabilities $4.72B, shareholders' equity $1.02B, long-term debt $686M
- Jun 30, 2025: cash $2.60B, total assets $6.38B, total liabilities $5.22B, shareholders' equity $1.16B, long-term debt $300M
- Mar 31, 2025: cash $2.24B, total assets $5.84B, total liabilities $4.51B, shareholders' equity $1.33B, long-term debt $300M
- Dec 31, 2024: cash $1.53B, total assets $4.84B, total liabilities $3.82B, shareholders' equity $1.01B, long-term debt $300M
- Sep 30, 2024: cash $1.21B, total assets $4.48B, total liabilities $3.32B, shareholders' equity $1.16B, long-term debt $299M
What is OSCR's revenue?
OSCAR HEALTH INC reported $15.3B of revenue over its last four quarters, through June 30, 2026.
Is OSCR profitable?
Yes. OSCAR HEALTH INC earned $551M over the last four quarters.
What is OSCR's EPS?
Diluted earnings per share over the last four quarters were $1.45; $1.10 in the latest quarter.